ChengDa Pharmaceuticals Co., Ltd. (SZSE: 301201)
Health Care · Pharmaceuticals · CN
CN¥30.09
-1.31% today · -5.2% 1Y
ChengDa Pharmaceuticals Co., Ltd. (SZSE: 301201) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $680.45M.
Over the last twelve months the share price has lost 5.2%, trading between 26.90 and 65.03.
Tweenvest scores ChengDa Pharmaceuticals Co., Ltd. across four factors: quality 76/100, value 35/100, growth 0/100, dividend 17/100. Its strongest factor is quality.
301201 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $680.45M
- Revenue (TTM)
- $70.58M
- P/E
- —
- EPS
- -0.15
- Dividend yield
- 0.66%
- Beta (5Y)
- -0.18
- 52-week high
- CN¥65.03
- 52-week low
- CN¥26.90
- Avg volume (3M)
- —
- Shares outstanding
- 151.47M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genomma Lab Internacional, S.A.B. de C.V.BMV: LAB B | $691.79M | MX$13.04 | +1.95% |
| Hunan Hansen Pharmaceutical Co., Ltd.SZSE: 002412 | $689.65M | CN¥9.18 | +1.21% |
| Mochida Pharmaceutical Co., Ltd.TSE: 4534 | $684.81M | ¥3,075.00 | -0.49% |
| Wave Life Sciences, Inc.NasdaqGM: WVE | $681.79M | $3.46 | -0.29% |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.SZSE: 002940 | $679.25M | CN¥23.20 | +1.05% |
| Zevra Therapeutics, Inc.NasdaqGS: ZVRA | $676.38M | $11.39 | +14.01% |
| Sinotherapeutics Inc.SHSE: 688247 | $668.33M | CN¥9.97 | -1.19% |
| PT Tempo Scan Pacific TbkIDX: TSPC | $662.85M | Rp2,630.00 | -0.38% |
Figures last refreshed Oct 11, 2026.